EYENOVIA, INC. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Eyenovia, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q2 2024.
Eyenovia, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$11.7M, a 96.1% decline year-over-year.
Eyenovia, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$35.9M, a 49.6% decline year-over-year.
Eyenovia, Inc. annual Operating Income (Loss) for 2023 was -$25.4M, a 5.59% increase from 2022.
Eyenovia, Inc. annual Operating Income (Loss) for 2022 was -$26.9M, a 107% decline from 2021.
Eyenovia, Inc. annual Operating Income (Loss) for 2021 was -$13M, a 34.2% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$35.9M	-$11.7M	-$5.73M	-96.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	-$30.2M	-$10.3M	-$4.81M	-88.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$25.4M	-$7.47M	-$2.09M	-39%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	-$23.3M	-$6.52M	+$710K	+9.82%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$24M	-$5.96M	+$1.16M	+16.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	-$25.2M	-$5.46M	+$1.73M	+24.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$26.9M	-$5.37M	-$8.43M	-276%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	-$18.5M	-$7.23M	-$1.31M	-22%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$17.2M	-$7.12M	-$2.34M	-48.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$14.8M	-$7.19M	-$1.82M	-33.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	-$13M	$3.05M	+$7.26M		Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$20.3M	-$5.93M	-$833K	-16.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$19.4M	-$4.78M	+$237K	+4.73%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$19.7M	-$5.37M	+$104K	+1.91%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-13
Q4 2020	-$19.8M	-$4.21M	+$1.08M	+20.5%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-30
Q3 2020	-$20.9M	-$5.09M	-$401K	-8.55%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$20.5M	-$5.02M	+$358K	+6.65%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$20.8M	-$5.47M	+$481K	+8.08%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	-$21.3M	-$5.29M	+$895K	+14.5%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-30
Q3 2019	-$22.2M	-$4.69M	-$371K	-8.58%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$21.8M	-$5.38M	-$2.06M	-61.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-14
Q1 2019	-$19.8M	-$5.95M	-$2.52M	-73.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	-$17.3M	-$6.18M	-$4.02M	-186%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-30
Q3 2018	-$13.2M	-$4.32M	-$3.44M	-388%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018	-$9.8M	-$3.32M	-$2.34M	-240%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	-$7.46M	-$3.43M	-$2.32M	-210%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q4 2017	-$5.13M	-$2.16M			Oct 1, 2017	Dec 31, 2017	10-K	2019-03-27
Q3 2017		-$885K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-13
Q2 2017		-$977K			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017		-$1.11M			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.